{"filing":{"accession_number":"0001213900-26-077368","cik":"0001877971","ticker":"POM","company_name":"POMDOCTOR Ltd","form":"6-K","filing_date":"2026-07-13","report_date":null,"primary_document":"ea0297796-6k_pomdoctor.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1877971/000121390026077368/ea0297796-6k_pomdoctor.htm"},"events":[{"id":17501,"run_id":15675,"accession_number":"0001213900-26-077368","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The press release announces that POMDOCTOR has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5450(a)(1), resolving a prior non-compliance notice issued on January 29, 2026. While the announcement is positive (compliance restored), the underlying event—a delisting risk triggered by failure to maintain minimum bid price—is material to investors. The disclosure directly addresses a continued listing rule and the threat of delisting that preceded it, making this a delisting_risk classification focused on the resolution of that material threat.","company_name":"POMDOCTOR Ltd","ticker":"POM","filing_date":"2026-07-13","form":"6-K","submitted_at":null,"items":[{"id":16001,"accession_number":"0001213900-26-077368","item_number":"EX-99.1","item_title":"ea029779601ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The press release announces that POMDOCTOR has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5450(a)(1), resolving a prior non-compliance notice issued on January 29, 2026. While the announcement is positive (compliance restored), the underlying event—a delisting risk triggered by failure to maintain minimum bid price—is material to investors. The disclosure directly addresses a continued listing rule and the threat of delisting that preceded it, making this a delisting_risk classification focused on the resolution of that material threat.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T12:06:48.517755+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16001,"accession_number":"0001213900-26-077368","item_number":"EX-99.1","item_title":"ea029779601ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The press release announces that POMDOCTOR has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5450(a)(1), resolving a prior non-compliance notice issued on January 29, 2026. While the announcement is positive (compliance restored), the underlying event—a delisting risk triggered by failure to maintain minimum bid price—is material to investors. The disclosure directly addresses a continued listing rule and the threat of delisting that preceded it, making this a delisting_risk classification focused on the resolution of that material threat.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T12:06:48.517755+00:00","company_name":"POMDOCTOR Ltd","ticker":"POM","filing_date":"2026-07-13"}]}